Company Filing History:
Years Active: 1983-1986
Title: Felix M Dietrich: Innovator in Vaccine Development
Introduction
Felix M Dietrich is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of immunology, particularly in the development of novel antigen derivatives. With a total of 3 patents, his work has the potential to enhance vaccine efficacy and improve public health outcomes.
Latest Patents
Dietrich's latest patents focus on antigen derivatives and processes for their preparation. The inventions relate to novel antigen derivatives that comprise an antigen and at least one muramylpeptide covalently bonded to it, potentially via a spacer. These pharmaceutical preparations are designed for use as vaccines. The novel antigen derivatives are shown to produce a pronounced increase in the immuno-response to the antigen, particularly enhancing cell-mediated immunity under clinically acceptable conditions of administration.
Career Highlights
Felix M Dietrich is associated with Ciba-Geigy Corporation, where he has been instrumental in advancing research in vaccine development. His innovative approaches have garnered attention in the scientific community, contributing to the understanding of immune responses.
Collaborations
Dietrich has collaborated with notable colleagues such as Gerhard Baschang and Roland Gisler. These partnerships have facilitated the exchange of ideas and expertise, further enriching the research environment.
Conclusion
Felix M Dietrich's contributions to vaccine development through his innovative patents highlight his role as a key figure in the field of immunology. His work continues to pave the way for advancements in vaccine technology and public health.